HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,000,228 | +1.9% | 78,540 | -3.8% | 0.01% | +10.0% |
Q2 2023 | $2,943,925 | -5.6% | 81,617 | 0.0% | 0.01% | -9.1% |
Q1 2023 | $3,116,953 | -32.9% | 81,617 | 0.0% | 0.01% | -38.9% |
Q4 2022 | $4,644,007 | +43.9% | 81,617 | 0.0% | 0.02% | +38.5% |
Q3 2022 | $3,227,000 | -10.1% | 81,617 | 0.0% | 0.01% | -7.1% |
Q2 2022 | $3,591,000 | +10.3% | 81,617 | 0.0% | 0.01% | +40.0% |
Q1 2022 | $3,255,000 | -0.8% | 81,617 | 0.0% | 0.01% | +11.1% |
Q4 2021 | $3,282,000 | -4.1% | 81,617 | -3.0% | 0.01% | -18.2% |
Q3 2021 | $3,423,000 | -6.1% | 84,140 | +4.8% | 0.01% | -8.3% |
Q2 2021 | $3,646,000 | +9.1% | 80,293 | +0.2% | 0.01% | 0.0% |
Q1 2021 | $3,341,000 | -18.6% | 80,150 | -16.6% | 0.01% | -20.0% |
Q4 2020 | $4,106,000 | +55.1% | 96,138 | -4.6% | 0.02% | +50.0% |
Q3 2020 | $2,647,000 | -6.2% | 100,726 | -4.3% | 0.01% | -16.7% |
Q2 2020 | $2,822,000 | +26.2% | 105,249 | -15.4% | 0.01% | +9.1% |
Q1 2020 | $2,237,000 | +1.5% | 124,360 | 0.0% | 0.01% | +37.5% |
Q4 2019 | $2,205,000 | -0.2% | 124,360 | -12.7% | 0.01% | -11.1% |
Q3 2019 | $2,210,000 | -49.6% | 142,500 | -44.1% | 0.01% | -43.8% |
Q2 2019 | $4,381,000 | +6.7% | 255,000 | 0.0% | 0.02% | +6.7% |
Q1 2019 | $4,106,000 | +10.1% | 255,000 | 0.0% | 0.02% | -6.2% |
Q4 2018 | $3,731,000 | -19.5% | 255,000 | 0.0% | 0.02% | -5.9% |
Q3 2018 | $4,633,000 | +7.7% | 255,000 | 0.0% | 0.02% | +6.2% |
Q2 2018 | $4,302,000 | -13.9% | 255,000 | 0.0% | 0.02% | -15.8% |
Q1 2018 | $4,995,000 | -3.3% | 255,000 | 0.0% | 0.02% | -5.0% |
Q4 2017 | $5,166,000 | +16.6% | 255,000 | 0.0% | 0.02% | +11.1% |
Q3 2017 | $4,429,000 | +91.9% | 255,000 | +41.7% | 0.02% | +100.0% |
Q2 2017 | $2,308,000 | -1.1% | 180,000 | 0.0% | 0.01% | -10.0% |
Q1 2017 | $2,333,000 | +31.2% | 180,000 | 0.0% | 0.01% | +25.0% |
Q4 2016 | $1,778,000 | -18.2% | 180,000 | 0.0% | 0.01% | -11.1% |
Q3 2016 | $2,174,000 | +40.0% | 180,000 | 0.0% | 0.01% | +28.6% |
Q2 2016 | $1,553,000 | -8.9% | 180,000 | 0.0% | 0.01% | -12.5% |
Q1 2016 | $1,705,000 | -72.7% | 180,000 | -50.0% | 0.01% | -38.5% |
Q4 2015 | $6,238,000 | +158.1% | 360,000 | +100.0% | 0.01% | +30.0% |
Q3 2015 | $2,417,000 | -40.5% | 180,000 | 0.0% | 0.01% | -37.5% |
Q2 2015 | $4,064,000 | +58.1% | 180,000 | 0.0% | 0.02% | +60.0% |
Q1 2015 | $2,570,000 | +48.0% | 180,000 | 0.0% | 0.01% | +42.9% |
Q4 2014 | $1,737,000 | +6.0% | 180,000 | 0.0% | 0.01% | +16.7% |
Q3 2014 | $1,638,000 | -7.9% | 180,000 | 0.0% | 0.01% | -14.3% |
Q2 2014 | $1,778,000 | – | 180,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
2Xideas AG | 600,799 | $22,950,522 | 2.54% |
BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |